Navigation Links
Synthetic HDL: A new weapon to fight cholesterol problems
Date:1/9/2009

EVANSTON, Ill. --- Buttery Christmas cookies, eggnog, juicy beef roast, rich gravy and creamy New York-style cheesecake. Happy holiday food unfortunately can send blood cholesterol levels sky high.

Northwestern University scientists now offer a promising new weapon -- synthetic high-density lipoprotein (HDL), the "good" cholesterol -- that could help fight chronically high cholesterol levels and the deadly heart disease that often results.

The researchers successfully designed synthetic HDL and show that their nanoparticle version is capable of irreversibly binding cholesterol. The synthetic HDL, based on gold nanoparticles, is similar in size to HDL and mimics HDL's general surface composition.

The study is published online by the Journal of the American Chemical Society (JACS).

"We have designed and built a cholesterol sponge. The synthetic HDL features the basics of what a great cholesterol drug should be," said Chad A. Mirkin, George B. Rathmann Professor of Chemistry in the Weinberg College of Arts and Sciences, professor of medicine and professor of materials science and engineering. Mirkin and Shad Thaxton, M.D., assistant professor of urology in Northwestern's Feinberg School of Medicine, led the study.

"Drugs that lower the bad cholesterol, LDL, are available, and you can lower LDL through your diet, but it is difficult to raise the good cholesterol, HDL," said Mirkin. "I've taken niacin to try and raise my HDL, but the side effects are bad so I stopped. We are hopeful that our synthetic HDL will one day help fill this gap in useful therapeutics."

In creating synthetic HDL the researchers started with a gold nanoparticle as the core. They then layered on a lipid that attaches to the gold surface, then another lipid and last a protein, called APOA1, the main protein component of naturally occurring HDL. The final high-density lipoprotein nanoparticles are each about 18 nanometers in diameter, a size similar to natural HDL.

"Cholesterol is essential to our cells, but chronic excess can lead to dangerous plaque formation in our arteries," said Thaxton. "HDL transports cholesterol to the liver, which protects against atherosclerosis. Our hope is that, with further development, our synthetic form of HDL could be used to increase HDL levels and promote better health."

"HDL is a natural nanoparticle, and we've successfully mimicked it," said Mirkin, director of Northwestern's International Institute for Nanotechnology. "Gold is an ideal scaffolding material -- it's size and shape can be tailored, and it can be easily functionalized. Using gold nanoparticles, which are non-toxic, for synthetic HDL bodes well for the development of a new therapeutic."

The development of synthetic HDL is a result of a successful collaboration between scientists in Northwestern's department of chemistry and the Feinberg School. Bringing these two groups together, says Mirkin, should lead to major advances in translational research. Their next step is to further study the synthetic HDL in biologically relevant conditions and measure and evaluate the cholesterol-binding properties.


'/>"/>

Contact: Marla Paul
marla-Paul@northwestern.edu
312-503-8928
Northwestern University
Source:Eurekalert

Related medicine news :

1. New center launched today to spearhead UK research in synthetic biology
2. Researcher refining synthetic molecules to prevent HIV resistance
3. FDA Approves Durameds Synthetic Conjugated Estrogens-A Vaginal Cream
4. Caltech engineers build first-ever multi-input plug-and-play synthetic RNA device
5. Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications
6. Pioneering Solutions To Fight Staph, MRSA Infections in Sports Facilities and Synthetic Turf Fields
7. Safety of Synthetic Turf Validated by NJ Test Results
8. Synthetic molecules hold promise for new family of anti-cancer drugs
9. Its Safe to Play on Desso Synthetic Turf
10. Experts Agree There is No Scientific Evidence of Health Risks in New Jersey Synthetic Turf Fields
11. Oregon study raises questions on synthetic progestins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2017)... ... July 28, 2017 , ... Lundquist Insurance Services, a family ... and families across east Texas, is embarking on a charity event in conjunction ... area. , America’s Mighty Warriors offers a series of programs for veterans that ...
(Date:7/28/2017)... ... 2017 , ... Leyden Insurance Agency, a Chicago based firm that offers asset ... County, is working in conjunction with the Conner T. Lowry Memorial Fund in a ... of a brave soldier who is still dearly missed by his community, the Connor ...
(Date:7/27/2017)... ... 2017 , ... Conventus, New Jersey’s premier professional liability insurer ... new educational series of webinars and podcasts to guide medical practices on understanding ... The first two episodes of the series, entitled “Pain Management and Opioids: New ...
(Date:7/27/2017)... (PRWEB) , ... July 27, 2017 , ... ... Diplomate of the American Board of Oral Implantology/Implant Dentistry (ABOI/ID). After successfully completing ... the nation’s leading providers of dental implants . Dr. Kimowitz and his ...
(Date:7/27/2017)... ... ... Standard Process is ushering in a new era of innovation with the ... (NCRC) in Kannapolis, North Carolina and by announcing a new leadership team, board and ... occupying over 10,000 square feet on the first floor of the David H. Murdock ...
Breaking Medicine News(10 mins):
(Date:7/26/2017)... Aesthetics, a leading medical aesthetic clinic in Singapore ... skin conditions from the inside. The natural process of ... skin becomes more transparent due to the thinning of the epidermis. Over ... the sun contributes to aging skin, causing age spots and other ... ...
(Date:7/25/2017)... BARCELONA, Spain and CAMBRIDGE, Massachusetts ... SOM Biotech, specializing in repurposing drugs to treat rare nervous ... Therapeutics Inc. to clinically develop and market the drug SOM0226 ... reached, the drug achieved very promising results in a Phase ... A new office in the United ...
(Date:7/24/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) announced ... operating results on Monday, August 7, 2017 after market ... p.m. ET. Shareholders ... of the conference call by dialing 877-201-0168 or 647-788-4901 ... 15 minutes prior to the call. A live webcast ...
Breaking Medicine Technology: